| 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer … JL Zamorano, P Lancellotti, D Rodriguez Munoz, V Aboyans, ... European heart journal 37 (36), 2768-2801, 2016 | 3345 | 2016 |
| Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European … JC Plana, M Galderisi, A Barac, MS Ewer, B Ky, M Scherrer-Crosbie, ... European Heart Journal–Cardiovascular Imaging 15 (10), 1063-1093, 2014 | 2487 | 2014 |
| Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy D Cardinale, A Colombo, G Bacchiani, I Tedeschi, CA Meroni, F Veglia, ... Circulation 131 (22), 1981-1988, 2015 | 1658 | 2015 |
| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T Lopez-Fernandez, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 1435 | 2022 |
| Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy D Cardinale, A Colombo, G Lamantia, N Colombo, M Civelli, ... Journal of the American College of Cardiology 55 (3), 213-220, 2010 | 1347 | 2010 |
| Prevention of high-dose chemotherapy–induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition D Cardinale, A Colombo, MT Sandri, G Lamantia, N Colombo, M Civelli, ... Circulation 114 (23), 2474-2481, 2006 | 1209 | 2006 |
| Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy D Cardinale, MT Sandri, A Colombo, N Colombo, M Boeri, G Lamantia, ... Circulation 109 (22), 2749-2754, 2004 | 1178 | 2004 |
| Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines G Curigliano, D Cardinale, T Suter, G Plataniotis, E de Azambuja, ... Annals of oncology 23, vii155-vii166, 2012 | 1051 | 2012 |
| Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations G Curigliano, D Lenihan, M Fradley, S Ganatra, A Barac, A Blaes, ... Annals of Oncology 31 (2), 171-190, 2020 | 843 | 2020 |
| Cardiotoxicity of anticancer treatments: epidemiology, detection, and management G Curigliano, D Cardinale, S Dent, C Criscitiello, O Aseyev, D Lenihan, ... CA: a cancer journal for clinicians 66 (4), 309-325, 2016 | 776 | 2016 |
| Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation D Cardinale, A Colombo, R Torrisi, MT Sandri, M Civelli, M Salvatici, ... Journal of Clinical Oncology 28 (25), 3910-3916, 2010 | 733 | 2010 |
| Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy D Cardinale, MT Sandri, A Martinoni, A Tricca LabTech, M Civelli, ... Journal of the American College of Cardiology 36 (2), 517-522, 2000 | 696 | 2000 |
| Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C … AR Lyon, S Dent, S Stanway, H Earl, C Brezden‐Masley, A Cohen‐Solal, ... European journal of heart failure 22 (11), 1945-1960, 2020 | 561 | 2020 |
| Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy D Cardinale, MT Sandri, A Martinoni, E Borghini, M Civelli, G Lamantia, ... Annals of Oncology 13 (5), 710-715, 2002 | 385 | 2002 |
| The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal … RN Rodseth, BM Biccard, Y Le Manach, DI Sessler, GA Lurati Buse, ... Journal of the American College of Cardiology 63 (2), 170-180, 2014 | 383 | 2014 |
| Cancer therapy–related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging MW Bloom, CE Hamo, D Cardinale, B Ky, A Nohria, L Baer, H Skopicki, ... Circulation: Heart Failure 9 (1), e002661, 2016 | 358 | 2016 |
| Cardiotoxicity of anthracyclines D Cardinale, F Iacopo, CM Cipolla Frontiers in cardiovascular medicine 7, 26, 2020 | 346 | 2020 |
| Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement J Herrmann, D Lenihan, S Armenian, A Barac, A Blaes, D Cardinale, ... European heart journal 43 (4), 280-299, 2022 | 318 | 2022 |
| N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: a marker predictive of cardiac dysfunction? MT Sandri, M Salvatici, D Cardinale, L Zorzino, R Passerini, P Lentati, ... Clinical chemistry 51 (8), 1405-1410, 2005 | 312 | 2005 |
| Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use A Dolci, R Dominici, D Cardinale, MT Sandri, M Panteghini American journal of clinical pathology 130 (5), 688-695, 2008 | 309 | 2008 |
